NASDAQ:PCSA | Free Cash Flow | Processa Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.59M
2025-12-31-$2.9M
2025-03-31-$2.73M
2024-12-31-$2.25M$0.00-$2.25M
2024-03-31-$2.05M
2023-12-31-$2.12M$0.00-$2.12M
2023-03-31-$2.11M
2022-12-31-$2.5M
2022-03-31-$1.8M
2021-12-31-$2.73M
2021-03-31-$2.24M
2020-12-31-$2.28M
2020-03-31-$546,453.00
2019-12-31-$613,486.00
2019-03-31-$607,429.00
2018-12-31-$463,976.00
2018-03-31-$1.07M
2017-12-31-$675,794.00
2017-03-31-$58,698.00$882.00-$59,580.00
2016-12-31-$2.12M
2016-03-31-$50,369.00
2015-12-31-$46,070.00$0.00-$46,070.00
2015-03-31-$502,088.00$1,399.00-$503,487.00
2014-12-31-$455,573.00-$14,712.00-$470,285.00
2014-03-31-$987,738.00$13,772.00-$1M
2013-12-31-$462,538.00$1.00-$462,539.00
2013-03-31-$592,973.00$6,276.00-$599,249.00
2012-12-31-$647,828.00$14,376.00-$662,204.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$11.39M
2024-12-31-$11.25M$3,244.00-$11.25M
2023-12-31-$8.06M$2,776.00-$8.07M
2022-12-31-$9.61M
2021-12-31-$8.72M
2020-12-31-$3.14M
2019-12-31-$2.75M
2018-12-31-$3.71M
2017-12-31-$1.65M$20,622.00-$1.68M
2016-12-31-$2.16M$23,775.00-$2.18M
2015-12-31-$871,906.00$1,399.00-$873,305.00
2014-12-31-$2.69M$11,007.00-$2.7M
2013-12-31-$2.54M$27,674.00-$2.57M
2012-12-31-$1.89M$334,338.00-$2.23M